Evidence map›Paper›PMID 37432503›Full record

Observational studyEuropean journal of pediatrics2023

Accurate diagnosis of acute hemorrhagic edema of infancy: a French multicenter observational study.

Sophie Leducq, Annabel Maruani, Christine Bodemer, Sandra Biscardi, Olivia Boccara, Marie-France Chinazzo, Emmanuel Mahé, Patrice Plantin, Sylvie Fraitag, Juliette Mazereeuw-Hautier and 10 more

Open access · greenAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 18 institutions in 2 countries.

Sophie LeducqDepartment of Dermatology and Reference Center for Rare Diseases and Vascular Malformations (MAGEC), Unit of Pediatric Dermatology, CHRU Tours, Tours, France. sophie.leducq@univ-tours.fr.
Annabel MaruaniDepartment of Dermatology and Reference Center for Rare Diseases and Vascular Malformations (MAGEC), Unit of Pediatric Dermatology, CHRU Tours, Tours, France.
Christine BodemerDepartment of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), APHP, Paris University, Necker-Enfants Malades Hospital, Paris Centre University, Imagine Institute, Paris, France.
Sandra BiscardiDepartment of Pediatrics, CHI Créteil, Créteil, France.
Olivia BoccaraDepartment of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), APHP, Paris University, Necker-Enfants Malades Hospital, Paris Centre University, Imagine Institute, Paris, France.
Marie-France ChinazzoDepartment of Pediatrics, CHRU Tours, Tours, France.
Emmanuel MahéDepartment of Dermatology, Hôpital Victor Dupouy, Argenteuil, France.
Patrice PlantinDepartment of Dermatology, Quimper, Quimper, CH, France.
Sylvie FraitagPathology Department, Necker-Enfants Malades Hospital, APHP, Paris, France.
Juliette Mazereeuw-HautierDepartment of Dermatology, CHU Toulouse, Toulouse, France.
Christine ChiaveriniDepartment of Dermatology, University Hospital of Nice, Nice, France.
Irene LemellePaediatric Onco-Haematology, Brabois Hospital, University Hospital of Nancy, Vandoeuvre-Lès-Nancy, France.
Didier BessisDepartment of Dermatology, University Hospital of Montpellier, Montpellier, France.
Emmanuelle BourratDepartment of General Pediatrics, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Stéphanie MalletDepartment of Dermatology, Hôpital Timone, Aix-Marseille Université, Marseille, France.
Bertille BonniaudDepartment of Dermatology and Genetics of Developmental Anomalies, UMR Inserm 1231, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079, Dijon, France.
Martine Grall-LeroseyDepartment of Pediatrics, CHU Rouen, Rouen, France.
Ludovic MartinDepartment of Dermatology, CHU Angers, Angers, France.
Franck BoraleviPediatric Dermatology Unit, Hôpital Pellegrin-Enfants, CHU de Bordeaux, France.
Maryam PiramDepartment of Pediatrics, CHU Sainte Justine Research Centre, Sainte Justine University Hospital, University of Montreal, Montreal, QC, Canada.
Inserm · FRAix-Marseille Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier de Cornouaille · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Tours · FRCentre Hospitalier Victor Dupouy · FRClinical Investigation Center Plurithematic Tours · FRHôpital Intercommunal de Créteil · FRHôpital Necker-Enfants Malades · FRHôpital Robert-Debré · FRInstitut des Maladies Génétiques Imagine · FRUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study is to highlight clinical signs that are either suggestive of or against the diagnosis of AHEI to improve diagnosis and management. The medical records of children under 3 years old diagnosed with AHEI were retrospectively reviewed. Clinical data and photographs were reviewed by three independent experts, and the cases were classified as probable, doubtful, or unclear AHEI. Of the 69 cases of children diagnosed with AHEI included in 22 centers, 40 were classified as probable, 22 as doubtful, and 7 as unclear. The median age of patients with probable AHEI was 11 months [IQR 9-15], and they were in overall good condition (n = 33/40, 82.5%). The morphology of the purpura was targetoid in 75% of cases (n = 30/40) and ecchymotic in 70% of cases (n = 28/40) and affected mostly the legs (n = 39/40, 97%), the arms (n = 34/40, 85%), and the face (n = 33/40, 82.5%). Edema was observed in 95% of cases and affected mostly the hands (n = 36/38, 95%) and feet (n = 28/38, 74%). Pruritus was absent in all patients with probable AHEI and described for 6/21 with doubtful AHEI (29%). AHEI was the original diagnosis in only 24 patients (n = 24/40, 60%). The major differential diagnoses were purpura fulminans and urticaria multiforme.  Conclusion: AHEI, which the diagnosis is made on clinical findings, is often misdiagnosed. Purpuric lesions localized on the face/ears, arms/forearms, and thighs/legs with edema of the hands without pruritus in a young child with a good overall condition are highly suggestive of AHEI. What is Known: •Acute hemorrhagic edema of infancy (AHEI) is a cutaneous leukocytoclastic vasculitis affecting children under 3 years old. •Appropriate diagnosis is important to distinguish this benign disease from more serious diseases to avoid investigations and treatments, iatrogenic harm and unnecessary follow-up. What is New: •AHEI is an uncommon disorder often misdiagnosed by pediatricians and dermatologists. •Purpuric lesions localized on the face/ears, arms/forearms, and thighs/legs with edema of the hands without pruritus in an infant with a good overall condition are highly suggestive of AHEI.

Indexed as

EdemaHemorrhageIgA VasculitisAcute DiseaseChild, PreschoolDiagnosis, DifferentialFemaleFranceHumansInfantMaleRetrospective StudiesAcute hemorrhagic edema of infancyFinkelstein-Seidlmayer vasculitisLeukocytoclastic vasculitisObservational studyPediatric dermatologyPurpura

Identifiers

PMID37432503
OpenAlexW4383873017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.